I. Casado Naranjo
University of Extremadura
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by I. Casado Naranjo.
Neurologia | 2014
J.C. López Fernández; J. Masjuan Vallejo; J. Arenillas Lara; M. Blanco González; E. Botia Paniagua; I. Casado Naranjo; E. Deyá Arbona; B. Escribano Soriano; M.M. Freijo Guerrero; Blanca Fuentes; J. Gállego Cullere; D. Geffners Sclarskyi; A. Gil Núñez; C. Gómez Escalonilla; A. Lago Martin; I. Legarda Ramírez; J.L. Maciñeiras Montero; J. Maestre Moreno; F. Moniche Álvarez; R. Muñoz Arrondo; F. Purroy García; J.M. Ramírez Moreno; M. Rebollo Álvarez Amandix; Jaume Roquer; F. Rubio Borrego; T. Segura; M. Serrano Ponza; J. Tejada García; C. Tejero Juste; J.A. Vidal Sánchez
INTRODUCTION The Spanish Health Systems stroke care strategy (EISNS) is a consensus statement that was drawn up by various government bodies and scientific societies with the aim of improving quality throughout the care process and ensuring equality among regions. Our objective is to analyse existing healthcare resources and establish whether they have met EISNS targets. MATERIAL AND METHODS The survey on available resources was conducted by a committee of neurologists representing each of Spains regions; the same committee also conducted the survey of 2008. The items included were the number of stroke units (SU), their resources (monitoring, neurologists on call 24h/7d, nurse ratio, protocols), SU bed ratio/100,000 inhabitants, diagnostic resources (cardiac and cerebral arterial ultrasound, advanced neuroimaging), performing iv thrombolysis, neurovascular interventional radiology (neuro VIR), surgery for malignant middle cerebral artery (MCA) infarctions and telemedicine availability. RESULTS We included data from 136 hospitals and found 45 Stroke Units distributed unequally among regions. The ratio of SU beds to residents ranged from 1/74,000 to 1/1,037,000 inhabitants; only the regions of Cantabria and Navarre met the target. Neurologists performed 3,237 intravenous thrombolysis procedures in 83 hospitals; thrombolysis procedures compared to the total of ischaemic strokes yielded percentages ranging from 0.3 to 33.7%. Hospitals without SUs showed varying levels of available resources. Neuro VIR is performed in every region except La Rioja, and VIR is only available on a 24h/7 d basis in 17 cities. Surgery for malignant MCA infarction is performed in 46 hospitals, and 5 have telemedicine. CONCLUSION Stroke care has improved in terms of numbers of participating hospitals, the increased use of intravenous thrombolysis and endovascular procedures, and surgery for malignant MCA infarction. Implementation of SUs and telemedicine remain insufficient. The availability of diagnostic resources is good in most SUs and irregular in other hospitals. Regional governments should strive to ensure better care and territorial equality, which would achieve the EISNS objectives.
Neurologia | 2013
P.E. Jiménez Caballero; F. López Espuela; J.C. Portilla Cuenca; R.M. Romero Sevilla; J.A. Fermín Marrero; I. Casado Naranjo
INTRODUCTION Type 1 neurofibromatosis is the most common neurocutaneous syndrome. Most published case series study the paediatric population. MATERIAL AND METHODS Cross-sectional study of cases of type 1 neurofibromatosis from neurology departments that were recorded in a database. We analysed the different clinical variables providing the diagnosis as well as demographic and neuroradiological variables. RESULTS We found a total of 31 patients with type 1 neurofibromatosis. The mean age was 28.9 years and 58.4% were women. Subjects with unidentified bright objects (UBOs) were younger than those without them (22.45±8.22 years vs. 32.5±10.64; P=.011). In contrast, subjects with neurofibromas were older than those without them (30.56±10.68 years vs. 18.25±4.34; P=.032). No sex differences were found in the presentation of clinical or radiological variables. Seven patients (22.6%) had tumours; 3 were optic pathway gliomas (1 bilateral), 3 were plexiform neurofibromas, and 1 was a pilocytic astrocytoma in the brainstem. CONCLUSIONS Patients with type 1 neurofibromatosis presented both peripheral neurofibromas and tumorous lesions of the central nervous system. Subjects with neurofibromas were older than those who did not present them, while subjects with UBOs were younger than those without such lesions.
Neurologia | 2017
F. López Espuela; J.C. Portilla Cuenca; C. Leno Díaz; J.M. Párraga Sánchez; G. Gamez-Leyva; I. Casado Naranjo
OBJECTIVE To evaluate long-term quality of life (QoL) in patients who have experienced a stroke and to analyse differences in QoL between sexes. METHODS We conducted a descriptive, cross-sectional, observational study to gather sociodemographic variables and risk factors; data were also obtained on QoL, mood, and functional status using validated scales. The study was approved by our centres ethics committee. RESULTS Our final sample included 124 patients; mean age was 71.30±11.99 years. In the QoL study, the EuroQol-5D dimensions in which participants presented most problems were anxiety/depression (66.7%) and pain/discomfort (62.2%). We found significant inter-sex differences in the dimensions of mobility and usual activities (P=.016 and P=.005, respectively). Women also achieved substantially poorer EuroQoL-5D index values than men (0.45±0.45 vs. 0.65±0.38; P=.013). QoL was found to be associated with dependence for the activities of daily living (r=0.326; P=.001) and depressed mood (r=-0.514; P<.0001). According to the predictive model for the EQ-5D index, 72% of the score on QoL items is explained by functional status, dependence for the activities of daily living (basic and instrumental), and depressed mood. Being married, in contrast, seems to be a protective factor. CONCLUSION Stroke survivors have poor long-term QoL; this is more marked in women than in men, especially in the dimensions of mobility and usual activities.
Neurologia | 2010
J.C. Portilla Cuenca; J.M. Ramírez-Moreno; L. Fernández de Alarcón; I. García Castañón; M. Caballero Muñoz; A. Serrano Cabrera; A. Falcón García; M. Gómez Gutiérrez; I. Casado Naranjo
INTRODUCTION Arteriosclerosis of the extra-cranial arteries is believed to be responsible for almost one-third of all ischaemic strokes. The sound diagnosis of the degree of stenosis is essential in deciding the best therapeutic strategy. Although cerebral angiography is considered the reference technique, ultrasound study (UST) is a more readily available, non-invasive and well-established procedure for quantifying carotid stenosis. However, on being a dependent exploratory technique, it is recommended that each laboratory validates its results against angiography. OBJECTIVES To establish the validity of the neuro-ultrasound study in our laboratory for use in the diagnosis of extracranial atheromatous disease, and determine its capacity to quantify the degree of stenosis in the internal carotid artery. MATERIAL AND METHODS A retrospective study of patients with extracranial carotid atheromatous disease, in whom the diagnostic process was carried out with carotid ultrasound as well as supra-aortic trunk digital-subtraction angiography. RESULTS A total of 254 carotids were evaluated and the degree of stenosis being classified into > 50%, 70-99% and 100%. The UST for the first group had a sensitivity (Se) of 97%, a specificity (Sp) of 90%, a positive predictive value (PPV) of 94.6% and a negative predictive value (NPV) of 94.2%. The second group had an Se of 96.4%, Sp 93%; PPV 94.4% and NPV 95.4%. The respective values for carotid occlusion were, 85%, 96.8%, 80% and 97.8%. CONCLUSIONS Our data validates the ability of UST performed in our Laboratory to diagnose the degree of carotid stenosis.
Revista Clinica Espanola | 2009
M.L. Calle Escobar; J.M. Ramírez-Moreno; M. Gómez Gutiérrez; N. Pacheco Gómez; G. Marcos Gómez; I. Casado Naranjo
Varon de 32 anos de origen boliviano residente en Espana desde hace 3 anos, sin antecedentes medicos de interes ni habitos toxicos. Como antecedentes familiares destaca tener un hermano portador de marcapasos defi nitivo por bradiarritmia y padre con cardiopatia dilatada y secuelas de un ictus isquemico. Ingresa en nuestro centro por un cuadro subito de alteracion en la expresion del lenguaje, sensacion de mareo y perdida de fuerza distal en el brazo derecho. En la exploracion se observa una afasia motora y una alteracion de la destreza manual derecha. Se realizan de forma urgente analitica, hemograma, coagulacion, radiografia de torax, tomografia axial computarizada (TAC) craneal, duplex de troncos supraorticos y doppler transcraneal con resultados normales. Con la sospecha de infarto cerebral isquemico parcial de la circulacion anterior ingresa en la Unidad de Ictus. Evoluciona favorablemente en las 48 horas siguientes y se completa el estudio con electrocardiograma (ECG) (fi g. 1) y ecocardiografia transtoracica (ETT) (fi gs. 2 y 3). La monitorizacion electrocardiografi ca durante 48 horas y posterior holter de arritmias fueron normales. Se solicito una prueba diagnostica.
Neurologia | 2011
J.C. López Fernández; J. Arenillas Lara; S. Calleja Puerta; E. Botia Paniagua; I. Casado Naranjo; E. Deyá Arbona; B. Escribano Soriano; M.M. Freijo Guerrero; D. Geffners Sclarsky; A. Gil Núñez; A. Gil Peralta; A. Gil Pujadas; C. Gómez Escalonilla; A. Lago Martin; J. Larracoechea Jausoro; I. Legarda Ramírez; J. Maestre Moreno; J.L. Manciñeiras Montero; S. Mola Caballero De Rodas; F. Moniche Álvarez; R. Muñoz Arrondo; J.A. Vidal Sánchez; F. Purroy García; J.M. Ramírez Moreno; M. Rebollo Álvarez Amandi; F. Rubio Borrego; T. Segura Martin; J. Tejada García; C. Tejero Juste; J. Masjuan Vallejo
Neurologia | 2014
J.C. López Fernández; J. Masjuan Vallejo; J. Arenillas Lara; M. Blanco González; E. Botia Paniagua; I. Casado Naranjo; E. Deyá Arbona; B. Escribano Soriano; M.M. Freijo Guerrero; Blanca Fuentes; J. Gállego Cullere; D. Geffners Sclarskyi; A. Gil Núñez; C. Gómez Escalonilla; A. Lago Martin; I. Legarda Ramírez; J.L. Maciñeiras Montero; J. Maestre Moreno; F. Moniche Álvarez; R. Muñoz Arrondo; F. Purroy García; J.M. Ramírez Moreno; M. Rebollo Álvarez Amandix; Jaume Roquer; F. Rubio Borrego; T. Segura; M. Serrano Ponza; J. Tejada García; C. Tejero Juste; J.A. Vidal Sánchez
Neurologia | 2014
P.E. Jiménez Caballero; J.A. Fermín Marrero; I. Trigo Bragado; I. Casado Naranjo
Neurologia | 2014
P.E. Jiménez Caballero; J.A. Fermín Marrero; I. Trigo Bragado; I. Casado Naranjo
Neurologia | 2011
J.C. López Fernández; J. Arenillas Lara; S. Calleja Puerta; E. Botia Paniagua; I. Casado Naranjo; E. Deyá Arbona; B. Escribano Soriano; M.M. Freijo Guerrero; D. Geffners Sclarsky; A. Gil Núñez; A. Gil Peralta; A. Gil Pujadas; C. Gómez Escalonilla; A. Lago Martin; J. Larracoechea Jausoro; I. Legarda Ramírez; J. Maestre Moreno; J.L. Manciñeiras Montero; S. Mola Caballero De Rodas; F. Moniche Álvarez; R. Muñoz Arrondo; J.A. Vidal Sánchez; F. Purroy García; J.M. Ramírez Moreno; M. Rebollo Álvarez Amandi; F. Rubio Borrego; T. Segura Martin; J. Tejada García; C. Tejero Juste; J. Masjuan Vallejo